Skip to content

An Open-Label Study of the Performance and Safety of the LiVac Retractor System in laparoscopic surgery

An Open-Label Study of the Performance and Safety of the LiVac Retractor System in laparoscopic surgery

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000704796
Enrollment
10
Registered
2013-06-27
Start date
2013-10-09
Completion date
2013-12-03
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Current methods of retracting the liver during surgery (to allow sight of and access to target surgical organs) can be traumatic or painful, and can require additional surgical assistants. The LiVac Retractor System has been developed to retract and hold the liver by suction, therefore reducing trauma and the need for extra assistance. This proof of concept study will assss how well the devices work during surgery and whether there are any safety issues.

Interventions

The LiVac Retractor and bevel device will be used during upper abdominal laparoscopic surgery on 10 patients to retract the liver and allow access to the target organs for surgery. The retractor is placed between the liver and diaphragm and uses suction to retract the liver. The bevel allows passage of the suction tube through surgical ports

Sponsors

LiVac Pty Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

- Male or female patients 18-65 years of age inclusive - Scheduled to undergo cholecystectomy for uncomplicated cholelithiasis or biliary pain, fundoplication or primary gastric banding laparoscopic surgery

Exclusion criteria

- Patients undergoing emergency procedures, revision surgery, or who have previously undergone major upper abdominal surgery - Pregnancy - Significant co-morbid disease or clinically significant medical conditions that in the investigator’s opinion, may increase the risk of surgery - Patients with common bile duct stones, active infection, BMI > 45 kg/m2, or history of chronic alcohol or drug abuse - Known Hepatitis B or C, or chronic liver disease with Childs-Pugh A, B or C, and/or cirrhosis - Patients with abnormal coagulation or who take anti-coagulation medication, or haematocrit less than 25 percent.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026